We have located links that may give you full text access.
Prolonged Achilles Tendon Vibration Does Not Alter the Neuromuscular Performance of Plantar Flexor Muscles.
Journal of Sport Rehabilitation 2016 July 22
CONTEXT: The prolonged tendon vibration may induce muscle fatigue, as assessed by a decrease in maximal force production. It remains however unknown whether the decrease in muscle strength after prolonged Achilles tendon vibration is related to the vibration frequency.
OBJECTIVE: This study aimed to assess the maximal capacity of plantar flexor neuromuscular function before and after prolonged Achilles tendon vibration at low and high frequencies generated using a portable device.
DESIGN: Pre- and post-test intervention with control.
SETTING: University laboratory.
PARTICIPANTS: Ten healthy males (age 22.6 ± 4.0 yrs).
INTERVENTION: Each subject participated in three experimental sessions that were randomly distributed and separated by one week. During each experimental session, one of the following vibration protocols was applied for 30 minutes: i) 40 Hz vibration, ii) 100 Hz vibration, or iii) no vibration (control protocol).
MAIN OUTCOME MEASURES: MVC torque, voluntary activation level, twitch torque, maximal electromyographic activity, and maximal M-wave of plantar flexor muscles (measured before and after each vibration or control protocol).
RESULTS: Statistical analysis exhibited no significant effect of vibration protocol on the measured variables.
CONCLUSIONS: The current study demonstrates that 30 min of Achilles tendon vibration at a low or high frequency using a portable stimulator did not affect the neuromuscular performance of the plantar flexor muscles. These results emphasize the limits of tendon vibration, whatever the frequency applied, for inducing neuromuscular fatigue.
OBJECTIVE: This study aimed to assess the maximal capacity of plantar flexor neuromuscular function before and after prolonged Achilles tendon vibration at low and high frequencies generated using a portable device.
DESIGN: Pre- and post-test intervention with control.
SETTING: University laboratory.
PARTICIPANTS: Ten healthy males (age 22.6 ± 4.0 yrs).
INTERVENTION: Each subject participated in three experimental sessions that were randomly distributed and separated by one week. During each experimental session, one of the following vibration protocols was applied for 30 minutes: i) 40 Hz vibration, ii) 100 Hz vibration, or iii) no vibration (control protocol).
MAIN OUTCOME MEASURES: MVC torque, voluntary activation level, twitch torque, maximal electromyographic activity, and maximal M-wave of plantar flexor muscles (measured before and after each vibration or control protocol).
RESULTS: Statistical analysis exhibited no significant effect of vibration protocol on the measured variables.
CONCLUSIONS: The current study demonstrates that 30 min of Achilles tendon vibration at a low or high frequency using a portable stimulator did not affect the neuromuscular performance of the plantar flexor muscles. These results emphasize the limits of tendon vibration, whatever the frequency applied, for inducing neuromuscular fatigue.
Full text links
Related Resources
Trending Papers
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app